Still outstanding: TRIUMPH-5 (head-to-head vs tirzepatide) TRIUMPH-6 (weight maintenance) and the MASH / MASLD readouts TRIUMPH-Outcomes (cardiovascular and kidney outcomes) -- a multi-year, event-driven trial Lilly said it plans to submit a Biologics License Application (BLA) for retatrutide to the FDA in the first quarter of 2027 , based on the core TRIUMPH results and supporting filings for obesity, obstructive sleep apnea, and knee osteoarthritis
Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval
According to the prescribing information, the recommended dosage regimen for the Wegovy pill is as follows
The need for continued treatment to maintain results is similar between medications, though semaglutides greater initial weight loss means more weight to potentially regain if stopped
314, Oct
Why Melanotan II keeps showing up online A lot of people want color without a burn